Nov 19, 2020
In this episode we explore the myriad of problems that result from media outlets treating corporate press releases as though they're legitimate news sources, rather than advertisements.
We examine "science by press release" cases ranging from psychedelic pharmaceutical firms who claim their barely-studied compounds are...
Nov 11, 2020
Recorded live at the Capital Psychedelic Summit, hosted virtually in Washington D.C., Russell Hausfeld joins Brian Normand and David Nickles to discuss the infiltration of the psychedelic pharmaceutical industry by companies, investors, and executives from extractive industry.
This episode explores the destructive...